Contraception
Volume 77, Issue 2 , Pages 114-117 , February 2008

Spanish women's attitudes towards menstruation and use of a continuous, daily use hormonal combined contraceptive regimen

  • Rafael Sánchez-Borrego

      Affiliations

    • Diatros, Well Women's Health Centres, 08850 Gava, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Diatros, Clínica de Atención a la Mujer, 08850 Gava, Barcelona, Spain. Tel.: +34 936381482; fax: +34 936383949.
    • ,
  • Carmen García-Calvo

      Affiliations

    • Medical Department, Wyeth Farma, 28700 San Sebastian de los Reyes, Madrid, Spain

Received 13 December 2006 ,Revised 25 April 2007 ,Accepted 7 May 2007.

References 

  1. Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey 1984 to 1992. Am J Public Health. 1996;86:195–199
  2. Sulak P. Ovulation suppression of premenstrual symptoms using oral contraceptives. Am J Manag Care. 2005;11(Suppl):S492–S497
  3. Davis A, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol. 2001;14:3–8
  4. Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States. Obstet Gynecol. 2002;100:683–687
  5. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol. 2000;95:261–266
  6. Anderson FD, Gibbons W, Portman D. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. Am J Obstet Gynecol. 2006;195:92–96
  7. Foidart JM, Sulak PJ, Schellschmidt I, Zimmermann D The Yasmin Extended Regimen Study Group. The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days. Contraception. 2006;73:34–40
  8. Nelson AL. Extended-regimen contraception: effects on menstrual symptoms and quality of life. J Fam Pract. 2006;52(Suppl.):S1–S8
  9. Kwiecien M, Edelman A, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003;67:9–13
  10. Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception. 2006;74:439–445
  11. Glasier AF, Smith KB, Van der Spuy ZM, et al. Amenorrhea associated with contraception — an international study on acceptability. Contraception. 2003;67:1–8
  12. Andrist LC, Arias RD, Nucatola D, et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004;70:359–363
  13. Sulak PJ, Buckley T, Kuehl TJ. Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives. Contraception. 2006;73:41–45
  14. Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69:37–42
  15. Eaton SB, Wood JW, Pike MC, et al. Women's reproductive cancers in evolutionary context. Q Rev Biol. 1994;69:353–367
  16. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science. 1993;259:633–638
  17. Strassmann BI. Menstrual cycle and breast cancer: an evolutionary perspective. J Womens Health. 1999;8:193–202
  18. Sucato GS, Gerschultz KL. Extended cycle hormonal contraception in adolescents. Curr Opin Obstet Gynecol. 2005;17:461–465
  19. Kaunitz AM. Menstruation: choosing whether … and when. Contraception. 2000;62:277–284

PII: S0010-7824(07)00283-1

doi: 10.1016/j.contraception.2007.05.082

Contraception
Volume 77, Issue 2 , Pages 114-117 , February 2008

Article Tools